Selected animal models: Vaginal candidosis, Pneumocystis pneumonia, dermatophytosis and trichosporonosis

Medical Mycology, Supplement

Volumn 36, Issue 1, 1998, Pages 129-136

  Sobel, J D ^a,h   Hasegawa, A ^b   Debernardis, F ^c   Adriani, D ^c   Pellegrini, G ^c   Cassone, A ^c   Fidel, P L ^d   Haidaris, C G ^e   Gigliotti, F ^e   Harmsen, A G ^e   Fujita, S ^f   Yamamoto, K ^g   Makimura, K ^g   Shibuya, K ^g   Uchida, K ^g   Yamaguchi, H ^g  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^f Tachikawa General Hospital   (Japan)

^g TEIKYO UNIVERSITY   (Japan)

^h Henry Ford Health System Division of Infectious Diseases   (United States)

Author keywords

Candidiasis; Dermatophytosis; Fungal disease; Pneumocystitis; Trichosporosis

Indexed keywords

ANTIINFECTIVE AGENT; IMMUNOSUPPRESSIVE AGENT; VIRULENCE FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; CANDIDIASIS; DERMATOMYCOSIS; DRUG METABOLISM; HOST RESISTANCE; HOST SUSCEPTIBILITY; MICROBIAL GENETICS; MOLECULAR BIOLOGY; MYCOSIS; NONHUMAN; PATHOGENESIS; PNEUMOCYSTIS PNEUMONIA; REVIEW; TRICHOSPORON;

ANIMALS; CANDIDIASIS, VULVOVAGINAL; DERMATOMYCOSES; DISEASE MODELS, ANIMAL; FEMALE; FUNGI; HUMANS; MYCOSES; PNEUMONIA, PNEUMOCYSTIS; TINEA PEDIS; TRICHOSPORON; VIRULENCE;

EID: 33747150743     PISSN: 09668454     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Cutler JE. Putative virulence factors of Candida albicans. Am Rev Microbiol 1991; 45: 187-218.
2. De Bernardis F, Cassone A, Sturtevant J, Calderone R Expression of Candida albicans SAP1 and SAP2 in experimental vaginitis. Infect Immun 1996; 63: 1887-92.
3. Hube B. Candida albicans secreted aspartyl proteinases. Curr Top Med Mycol 1996; 7: 55-69.
4. Ruchel R, De Bernardis F, Ray TJ, Sullivan PA, Cole GT. Candida acid proteinase J Med Vet Mycol 1992; 30 (Suppl 1): 123-32.
5. Hube B, Monod M, Schofield A, Brown AJP, Gow NAR. Expression of seven members of the gene family encoding secretory aspartyl proteinases in Candida albicans. Mol Microbiol 1994; 10: 859-66.
6. Cassone A, Boccanera M, Adriani D, Santoni G, De Bernardis F. Rats clearing a vaginal infection by Candida albicans acquire specific, antibody-mediated resistance to vaginal reinfection. Infect Immun 1995; 63: 2619-24.
7. Sobel JD. Pathogenesis and epidemiology of vulvovaginal candidiasis. Ann N Y Acad Sci 1988; 544: 547-57.
8. Odds FC. Chronic mucocutaneous candidosis. In: Candida and Candidosis. Baltimore: University Park Press, 1988: 104-10.
9. Fidel PL, Lynch ME, Redondo-Lopez V, Sobel JD, Robinson R. Systemic cell-mediated immune reactivity in women with recurrent vulvovaginal candidiasis (RVVC). J Infect Dis 1993; 168: 1458-65.
10. Fidel PL, Lynch ME, Sobel JD. Candida-specific Th1-type responsiveness in mice with experimental vaginal candidiasis. Infect Immun 1993; 61: 4202-7.
11. Fidel PL, Lynch ME, Sobel JD. Effects of pre-induced Candida-specific systemic cell-mediated immunity on experimental vaginal candidiasis. Infect Immun 1994; 62: 1032-8.
12. Fidel PL, Lynch ME, Conaway DH, Tait L, Sobel JD. Mice immunized by primary vaginal C. albicans infection develop acquired vaginal mucosal immunity. Infect Immun 1995; 63: 547-53.
13. Fidel PL, Lynch ME, Sobel JD. Circulating CD4 and CD8 T cells have little impact on host defense against experimental vaginal candidiasis. Infect Immun 1995; 63: 2403-8.
14. Fidel PL, Cutright JL, Sobel JD. Effects of systemic cell-mediated immunity on vaginal candidiasis in mice resistant and susceptible to Candida albicans infections. Infect Immun 1995; 63: 4191-4.
15. Fidel PL, WoIf NA, KuKuruga MA. T lymphocytes in the murine vaginal mucosa are phenotypically distinct from those in the periphery. Infect Immun 1996; 37: 93-9.
16. Ozenci H, Scott M, Luo W, et al. Growth inhibition of Candida albicans by vaginal cells from naive mice. American Society for Microbiology Annual Meeting, 1997: Abst F-107.
17. Fidel PL, Cutright JL, Tait L, Sobel JD. A murine model of Candida glabrata vaginitis. J Infect Dis, 1996; 173: 425-31.
18. Fidel PL, Cutright JL, Sobel JD. Efficacy of DO870 treatments of experimental Candida vaginitis Antimic Ag Chemother 1997; 41: 1455-61.
19. Masur H, Lane HC, Kovacs JA, Alegra CJ, Edman JC. Pneumocystis pneumonia: From bench to clinic. Ann Int Med 1989; 111: 813-26.
20. Sloand E, Laughon B, Armstrong M. et al. The challenge of Pneumocystis carinii culture. J Euk Microbiol 1993; 40: 188-95.
21. Hughes WT. Pneumocystis carinii. Boca Raton, FL. CRC Press, Inc., 1987: Vols 1 & 2.
22. Gigliotti F, Haidaris CG. Antigenic characterization of Pneumocystis carinii. In: Limper AH, ed. Seminars in Respiratory Infections: Pneumocystis carinii From the Bedside to the Bench and Back Again, (in press).
23. Stringer JR. Pneumocystis carinii: What is it, exactly? Clin Microbiol Rev 1996; 9: 489-98.
24. Gigliotti F, Harmsen AG, Haidaris CG, Haidaris PJ. Pneumocystis carinii is not universally transmissible between species Infect Immun 1993; 61: 2886-90.
25. Aliouat EM, Mazars E, Dei-Cas E, et al. Pneumocystis cross infection experiments, using SCID mice and nude rats as recipient host, showed strong host species specificity. J Euk Microbiol 1994; 41: 71S.
26. Chen W, Gigliotti F, Harmsen AG. Latency is not an inevitable outcome of infection with Pneumocystis carinii. Infect Immun 1993; 61: 5406-9.
27. Harmsen AG, Chen W, Gigliotti F. Active immunity to Pneumocystis carinii reinfection in T-cell depleted mice. Infect Immun 1995; 63: 2391-5.
28. Gigliotti F, Hughes WT. Passive immunoprophylaxis with specific monoclonal antibody confers partial protection against Pneumocystis carinii pneumonia in animal models. J Clin Invest 1988; 81: 1666-8.
29. Gigliotti F, McCool T. Glycoprotein A is the immunodominant antigen of Pneumocystis carinii in mice following immunization. Parasitol Res 1996; 82: 90-1.
30. Haidaris CG, Lee LH, Simpson-Haidaris PJ, Gigliotti F. Characterization of novel surface antigens of mouse Pneumocystis carinii. Abstracts of the 13th Congress of the JSHAM P-287, p. 150, 1997.
31. Wright TW, Simpson-Haidaris PJ, Gigliotti F, Harmsen AG, Haidaris CG. Conserved sequence homology of cysteine rich regions in genes encoding glycoprotein A in Pneumocystis carinii derived from different host species. Infect Immun 1994; 62: 1513-9.
32. Wright TW, Gigliotti F, Haidaris CG, Simpson-Haidaris PJ. Cloning and characterization of a conserved region of human and Rhesus macaque Pneumocystis carinii gpA genes. Gene 1995; 167: 185-9.
33. Fujita S, Matsuyama T, Sato Y. A simple and reliable culturing method for production of arthrospores by dermatophytes. Jpn J Med Mycol 1986; 27: 175-81.
34. Fujita S, Matsuyama T. Experimental tinea pedis induced by non-abrasive inoculation of Trichophyton mentagrophytes arthrospores on the plantar part of a guinea pig foot. J Med Vet Mycol 1987; 25; 203-13.
35. Arika T, Yokoo M, Haise T, et al. Effect of butenafine hydrochloride a new benzylamine derivative, on experimental tinea pedis in guinea pigs. Antimicrob Agents Chemother 1990; 34: 2250-3.
36. Ohmi T, Konaka S, Uchida M. et al. Antifungal activity of new agent latoconazole in two tinea models. Arzneim-Forsch/Drug Res 1991; 41: 847-51.
37. Uchida K, Kudoh M, Yamaguchi H. A study on effectiveness of treatment and prevention of relapse using topical administration of terbinafine in a guinea pig model for tinea pedis. Jpn J Antibiot 1994; 47: 1407-12.
38. Kalter DC, Tschen JA, Cemoch PL, et al. Genital white piedra: epidemiology, microbiology, and therapy. J Am Acad Dermat 1986; 14: 982-93.
39. Kamalam A, Sentharnilselvi G, Ajithadas K, Thambiah AS. Cutaneous trichosporonosis. Mycopathologia 1988; 101: 167-75.
40. Ando M, Arima K, Yoneda R, Tamura M. Japanese summer-type hypersensitivity pneumonitis. Geographic distribution, home environment, and clinical characteristics of 621 cases. Am Rev Respir Dis 1991; 144: 765-9.
41. Yoshida K, Ando M, Skata T, Araki S. Environmental sycological studies on the causative agent of summer-type hypersensitivity pneumonitis. J All Clin Immun 1988; 81: 475-83.
42. Anaissie E, Bodey GP, Kantarjian H, et al. New spectrum of fungal infections in patients with cancer. Rev Infect Dis 1989; 11: 369-78.
43. Guého E, Faergemann J, Lyman C, Anaissie E. Malassezia and Trichosporon: two emerging pathogenic basidiomycetous yeast-like fungi. J Med Vet Mycol 1994; 32: 367-78.